These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35890129)

  • 1. Pentagalloyl Glucose and Cisplatin Combination Treatment Exhibits a Synergistic Anticancer Effect in 2D and 3D Models of Head and Neck Carcinoma.
    Kantapan J; Intachai N; Khamto N; Meepowpan P; Sangthong P; Wantanajittikul K; Dechsupa N; Chitapanarux I
    Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of head and neck cancer cell survival and cisplatin resistance by GRP78 small molecule inhibitor YUM70.
    Yamamoto V; Wang B; Lee AS
    Front Oncol; 2022; 12():1044699. PubMed ID: 36713577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallotannin from
    Kantapan J; Dechsupa N; Tippanya D; Nobnop W; Chitapanarux I
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
    Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
    Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.
    Jiang M; Liu Z; Xiang Y; Ma H; Liu S; Liu Y; Zheng D
    BMC Cancer; 2011 Feb; 11():54. PubMed ID: 21291526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penta-O-galloyl-β-D-glucose attenuates cisplatin-induced nephrotoxicity via reactive oxygen species reduction in renal epithelial cells and enhances antitumor activity in Caki-2 renal cancer cells.
    Ryu HG; Jeong SJ; Kwon HY; Lee HJ; Lee EO; Lee MH; Choi SH; Ahn KS; Kim SH
    Toxicol In Vitro; 2012 Mar; 26(2):206-14. PubMed ID: 22172427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy.
    Hagege A; Ambrosetti D; Boyer J; Bozec A; Doyen J; Chamorey E; He X; Bourget I; Rousset J; Saada E; Rastoin O; Parola J; Luciano F; Cao Y; Pagès G; Dufies M
    Theranostics; 2021; 11(19):9571-9586. PubMed ID: 34646387
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion.
    Sarnella A; Ferrara Y; Auletta L; Albanese S; Cerchia L; Alterio V; De Simone G; Supuran CT; Zannetti A
    J Exp Clin Cancer Res; 2022 Apr; 41(1):122. PubMed ID: 35365193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentagalloyl Glucose-Targeted Inhibition of P-Glycoprotein and Re-Sensitization of Multidrug-Resistant Leukemic Cells (K562/ADR) to Doxorubicin: In Silico and Functional Studies.
    Dechsupa N; Khamto N; Chawapun P; Siriphong S; Innuan P; Suwan A; Luangsuep T; Photilimthana N; Maita W; Thanacharttanatchaya R; Sangthong P; Meepowpan P; Udomtanakunchai C; Kantapan J
    Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with cisplatin and the tankyrase inhibitor XAV-939 increases cytotoxicity, abrogates cancer-stem-like cell phenotype and increases chemosensitivity of head-and-neck squamous-cell carcinoma cells.
    Roy S; Roy S; Kar M; Chakraborty A; Kumar A; Delogu F; Asthana S; Hande MP; Banerjee B
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Oct; 846():503084. PubMed ID: 31585633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.
    Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I
    Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer.
    Chitcholtan K; Sykes PH; Evans JJ
    J Transl Med; 2012 Mar; 10():38. PubMed ID: 22394685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels.
    Okamoto H; Yoshikawa K; Shimada A; Sano R; Inukai D; Yamanaka S; Suzuki S; Ueda R; Ueda H; Fujimoto Y; Ogawa T
    Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37350399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.
    Huang Z; Li H; Huang Q; Chen D; Han J; Wang L; Pan C; Chen W; House MG; Nephew KP; Guo Z
    Mol Carcinog; 2014 Oct; 53(10):777-86. PubMed ID: 23661500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of head and neck cancer to cisplatin through the use of a novel curcumin analog.
    Abuzeid WM; Davis S; Tang AL; Saunders L; Brenner JC; Lin J; Fuchs JR; Light E; Bradford CR; Prince ME; Carey TE
    Arch Otolaryngol Head Neck Surg; 2011 May; 137(5):499-507. PubMed ID: 21576562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentagalloyl glucose inhibits TNF-α-activated CXCL1/GRO-α expression and induces apoptosis-related genes in triple-negative breast cancer cells.
    Mendonca P; Alghamdi S; Messeha S; Soliman KFA
    Sci Rep; 2021 Mar; 11(1):5649. PubMed ID: 33707603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer.
    Kumar B; Yadav A; Hideg K; Kuppusamy P; Teknos TN; Kumar P
    PLoS One; 2014; 9(3):e93208. PubMed ID: 24675768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentagalloyl Glucose: A Review of Anticancer Properties, Molecular Targets, Mechanisms of Action, Pharmacokinetics, and Safety Profile.
    Wen C; Dechsupa N; Yu Z; Zhang X; Liang S; Lei X; Xu T; Gao X; Hu Q; Innuan P; Kantapan J; Lü M
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma.
    Lang L; Shay C; Zhao X; Xiong Y; Wang X; Teng Y
    J Hematol Oncol; 2019 Dec; 12(1):132. PubMed ID: 31805962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with acetazolamide and cisplatin enhances the chemosensitivity of human head and neck squamous cell carcinoma TU868 cells.
    Jia T; Ming SX; Cao QQ; Xu FL
    Arch Oral Biol; 2020 Nov; 119():104905. PubMed ID: 32947166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.